Cadence Bank (CADE) Investigated for Shareholder Rights in Huntington Acquisition
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 10 2025
0mins
Source: Globenewswire
- Acquisition Investigation: Halper Sadeh LLC is investigating Cadence Bank (NYSE: CADE) regarding its sale to Huntington Bancshares Incorporated, which involves an exchange of 2.475 shares of common stock for each outstanding share, potentially violating shareholder rights.
- Legal Rights: The firm is also looking into Mersana Therapeutics, Inc. (NASDAQ: MRSN) and its sale to Day One Biopharmaceuticals, Inc., urging shareholders to understand their legal rights and options.
- Cash Acquisition: Cidara Therapeutics, Inc. (NASDAQ: CDTX) is being sold to Merck for $221.50 per share in cash, a transaction that is also under scrutiny by Halper Sadeh LLC, which may impact shareholder interests.
- Legal Support: Halper Sadeh LLC offers contingent fee legal services to affected shareholders, aiming to secure increased consideration and additional disclosures, highlighting their commitment to protecting shareholder rights.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
